Cartesian Therapeutics, Inc. (RNAC): Net Income
-$130.30M
Year ended 2025-12-31
-$151.89M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$130.30M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$77.42M | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$219.71M | n/m | 2025-03-13, From 2023-01-01 |
| 2022-12-31 | $35.38M | n/m | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | -$25.69M | n/m | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | -$68.88M | n/m | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | -$55.35M | n/m | 2022-03-10, From 2019-01-01 |
| 2018-12-31 | -$65.34M | n/m | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$65.32M | n/m | 2020-03-12, From 2017-01-01 |
| 2016-12-31 | -$36.21M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$25.17M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$12.88M | n/a | 2017-03-28, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | -$130.30M | n/m |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | -$143.44M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.68M | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$569.0K | n/m |
| GeoVax Labs, Inc. (GOVX) | 2025-12-31 | -$21.46M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$80.40M | n/m |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$12.16M | n/m |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | -$3.53M | n/m |
| Dianthus Therapeutics, Inc. (DNTH) | 2025-12-31 | -$162.34M | n/m |
Compare RNAC, UPB, XBIO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗